Alteration of tumor suppressors changes the endometrial tumor spectrum
The most common gynecological cancer in Europe and the United States is endometrial. Like most cancers, early‐stage endometrial cancer has a more favorable prognosis, while high‐grade, including endometrioid and nonendometrioid, has the worst prognosis. In endometrioid human tumors, the tumor suppre...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2023-10-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.202318166 |